310 related articles for article (PubMed ID: 21865089)
1. HIV controllers: a multifactorial phenotype of spontaneous viral suppression.
Thèze J; Chakrabarti LA; Vingert B; Porichis F; Kaufmann DE
Clin Immunol; 2011 Oct; 141(1):15-30. PubMed ID: 21865089
[TBL] [Abstract][Full Text] [Related]
2. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity in HIV controllers: the right place at the right time.
Shacklett BL; Ferre AL
Curr Opin HIV AIDS; 2011 May; 6(3):202-7. PubMed ID: 21399497
[TBL] [Abstract][Full Text] [Related]
4. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.
Gonzalez SM; Taborda NA; Correa LA; Castro GA; Hernandez JC; Montoya CJ; Rugeles MT
Immunol Res; 2016 Jun; 64(3):765-74. PubMed ID: 26724942
[TBL] [Abstract][Full Text] [Related]
5. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
[TBL] [Abstract][Full Text] [Related]
6. Elite control of HIV: is this the right model for a functional cure?
Cockerham LR; Hatano H
Trends Microbiol; 2015 Feb; 23(2):71-5. PubMed ID: 25487109
[TBL] [Abstract][Full Text] [Related]
7. HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.
Hunt PW; Hatano H; Sinclair E; Lee TH; Busch MP; Martin JN; McCune JM; Deeks SG
Clin Infect Dis; 2011 Mar; 52(5):681-7. PubMed ID: 21245154
[TBL] [Abstract][Full Text] [Related]
8. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.
Hunt PW; Landay AL; Sinclair E; Martinson JA; Hatano H; Emu B; Norris PJ; Busch MP; Martin JN; Brooks C; McCune JM; Deeks SG
PLoS One; 2011 Jan; 6(1):e15924. PubMed ID: 21305005
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers.
Gaardbo JC; Ronit A; Hartling HJ; Gjerdrum LM; Springborg K; Ralfkiær E; Thorsteinsson K; Ullum H; Andersen ÅB; Nielsen SD
J Acquir Immune Defic Syndr; 2014 Jan; 65(1):10-8. PubMed ID: 23995946
[TBL] [Abstract][Full Text] [Related]
10. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
11. Th17 cells and regulatory T cells in elite control over HIV and SIV.
Hartigan-O'Connor DJ; Hirao LA; McCune JM; Dandekar S
Curr Opin HIV AIDS; 2011 May; 6(3):221-7. PubMed ID: 21399494
[TBL] [Abstract][Full Text] [Related]
12. Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.
Hu H; Nau M; Ehrenberg P; Chenine AL; Macedo C; Zhou Y; Daye ZJ; Wei Z; Vahey M; Michael NL; Kim JH; Marovich M; Ratto-Kim S
Blood; 2013 Feb; 121(7):1136-44. PubMed ID: 23258923
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
Emu B; Sinclair E; Favre D; Moretto WJ; Hsue P; Hoh R; Martin JN; Nixon DF; McCune JM; Deeks SG
J Virol; 2005 Nov; 79(22):14169-78. PubMed ID: 16254352
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.
Chen H; Li C; Huang J; Cung T; Seiss K; Beamon J; Carrington MF; Porter LC; Burke PS; Yang Y; Ryan BJ; Liu R; Weiss RH; Pereyra F; Cress WD; Brass AL; Rosenberg ES; Walker BD; Yu XG; Lichterfeld M
J Clin Invest; 2011 Apr; 121(4):1549-60. PubMed ID: 21403397
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of host restriction factors in HIV-1 elite controllers.
Abdel-Mohsen M; Raposo RA; Deng X; Li M; Liegler T; Sinclair E; Salama MS; Ghanem Hel-D; Hoh R; Wong JK; David M; Nixon DF; Deeks SG; Pillai SK
Retrovirology; 2013 Oct; 10():106. PubMed ID: 24131498
[TBL] [Abstract][Full Text] [Related]
18. Virus-host interactions in HIV pathogenesis: directions for therapy.
Levy JA
Adv Dent Res; 2011 Apr; 23(1):13-8. PubMed ID: 21441474
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses.
Sáez-Cirión A; Shin SY; Versmisse P; Barré-Sinoussi F; Pancino G
Nat Protoc; 2010 Jun; 5(6):1033-41. PubMed ID: 20539279
[TBL] [Abstract][Full Text] [Related]
20. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
